188
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

CD22 expression in acute myeloid leukemia: close correlation with interleukin-2 receptor α-chain (CD25) expression and poor prognosis

, , &
Pages 2251-2253 | Received 08 Dec 2021, Accepted 29 Mar 2022, Published online: 20 Apr 2022
 

Acknowledgments

We gratefully acknowledge the late Dr. K. Kita (Japan Baptist Hospital, Kyoto, Japan) for suggesting the conception of this paper. We are also grateful to the late Dr. T. Uchiyama (Kyoto University, Kyoto, Japan), Dr. R. Ueda (Aichi Cancer Center, Nagoya, Japan), Dr. T. Kitamura (Tokyo University, Tokyo, Japan), and Dr. E. Tatsumi (Kobe University, Kobe, Japan) for supplying mAb. We thank Drs. T. Kyo and H. Dohy (Hiroshima Red Cross Atomic-Bomb Survivors Hospital, Hiroshima, Japan), H. Tsutani and T. Ueda (Fukui University, Fukui, Japan), K. Nasu (Osaka Red Cross Hospital, Osaka, Japan), K. Kawakami (Suzuka Chuo Hospital, Suzuka, Japan), K. Oka (Suzuka Kaisei Hospital, Suzuka, Japan), T. Sekine (Matsusaka Chuo Hospital, Matsusaka, Japan) for important information.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the promotion of Science [Grant 63570570 and 06454346].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.